Alessandro Rambaldi

60.7k total citations · 4 hit papers
661 papers, 24.3k citations indexed

About

Alessandro Rambaldi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alessandro Rambaldi has authored 661 papers receiving a total of 24.3k indexed citations (citations by other indexed papers that have themselves been cited), including 323 papers in Hematology, 247 papers in Genetics and 154 papers in Molecular Biology. Recurrent topics in Alessandro Rambaldi's work include Acute Myeloid Leukemia Research (162 papers), Acute Lymphoblastic Leukemia research (124 papers) and Lymphoma Diagnosis and Treatment (115 papers). Alessandro Rambaldi is often cited by papers focused on Acute Myeloid Leukemia Research (162 papers), Acute Lymphoblastic Leukemia research (124 papers) and Lymphoma Diagnosis and Treatment (115 papers). Alessandro Rambaldi collaborates with scholars based in Italy, United States and France. Alessandro Rambaldi's co-authors include Tiziano Barbui, Martino Introna, Josée Golay, Andrea Biondi, Alessandro M. Vannucchi, Guido Finazzi, Alessandra Carobbio, Gianmaria Borleri, Christian Gluud and Paola Guglielmelli and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Alessandro Rambaldi

633 papers receiving 23.7k citations

Hit Papers

Standardized RT-PCR analysis of fusion gene transcripts f... 1999 2026 2008 2017 1999 2014 2017 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
    1999 865 citations Alessandro Rambaldi, Andrea Biondi et al. Leukemia profile →
  2. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
    2014 493 citations Ayalew Tefferi, Paola Guglielmelli et al. Blood profile →
  3. Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
    2017 298 citations Giovanni Martinelli, Nicolas Boissel et al. Journal of Clinical Oncology profile →
  4. Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
    2020 274 citations Robin Foà, Renato Bassan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Rambaldi Italy 83 9.6k 8.5k 8.1k 5.6k 4.9k 661 24.3k
Maher Albitar United States 65 9.2k 1.0× 8.2k 1.0× 7.5k 0.9× 4.5k 0.8× 3.4k 0.7× 342 20.0k
Deborah A. Thomas United States 80 12.3k 1.3× 10.2k 1.2× 6.3k 0.8× 4.9k 0.9× 3.0k 0.6× 451 23.2k
John F. Seymour Australia 74 7.9k 0.8× 10.7k 1.3× 5.1k 0.6× 6.8k 1.2× 3.7k 0.7× 561 23.8k
James D. Griffin United States 95 12.4k 1.3× 6.3k 0.7× 12.8k 1.6× 7.4k 1.3× 5.3k 1.1× 354 29.7k
Zeev Estrov United States 82 13.3k 1.4× 10.5k 1.2× 11.7k 1.4× 4.8k 0.9× 3.5k 0.7× 669 26.3k
Tadeusz Robak Poland 59 5.8k 0.6× 10.0k 1.2× 5.3k 0.7× 5.0k 0.9× 5.3k 1.1× 712 19.3k
Stefan Faderl United States 88 17.0k 1.8× 10.9k 1.3× 8.2k 1.0× 5.3k 0.9× 2.8k 0.6× 570 27.0k
William G. Wierda United States 88 11.0k 1.1× 18.2k 2.1× 8.5k 1.1× 8.1k 1.4× 8.2k 1.7× 829 31.7k
Wolfgang Hiddemann Germany 79 11.0k 1.1× 6.9k 0.8× 8.1k 1.0× 9.3k 1.6× 3.1k 0.6× 644 27.2k
Michele Baccarani Italy 80 20.3k 2.1× 14.6k 1.7× 4.9k 0.6× 5.9k 1.1× 3.1k 0.6× 711 29.1k

Countries citing papers authored by Alessandro Rambaldi

Since Specialization
Citations

This map shows the geographic impact of Alessandro Rambaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Rambaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Rambaldi more than expected).

Fields of papers citing papers by Alessandro Rambaldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Rambaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Rambaldi. The network helps show where Alessandro Rambaldi may publish in the future.

Co-authorship network of co-authors of Alessandro Rambaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Rambaldi. A scholar is included among the top collaborators of Alessandro Rambaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Rambaldi. Alessandro Rambaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schoettler, Michelle Long, Narinder Nangia, Miguel‐Angel Perales, et al.. (2025). Narsoplimab Treatment for Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA) – Real World Outcomes from an Expanded Access Program. Transplantation and Cellular Therapy. 31(2). S25–S25. 1 indexed citations
3.
Barbui, Tiziano, Alessandra Carobbio, Arianna Ghirardi, et al.. (2024). Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis. Blood Cancer Journal. 14(1). 195–195. 5 indexed citations
4.
Foglia, Emanuela, Alessandro Rambaldi, Roberto Cairoli, et al.. (2023). Multidimensional Results and Reflections on CAR-T: The Italian Evidence. International Journal of Environmental Research and Public Health. 20(5). 3830–3830. 6 indexed citations
5.
Micò, Maria Caterina, Anna Grassi, Alessandra Algarotti, et al.. (2023). Clinical Safety and Efficacy of Narsoplimab in Pediatric and Adult Patients with Transplant-Associated Thrombotic Microangiopathy: A Real-World Experience. Blood. 142(Supplement 1). 3543–3543. 1 indexed citations
6.
Foà, Robin, Renato Bassan, Loredana Elia, et al.. (2023). Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. Journal of Clinical Oncology. 42(8). 881–885. 56 indexed citations
7.
Khaled, Samer K., Jaap Jan Boelens, Mitchell S. Cairo, et al.. (2021). Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA). Transplantation and Cellular Therapy. 27(3). S24–S26. 2 indexed citations
8.
Gotlib, Jason, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, et al.. (2021). A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1). Blood. 138(Supplement 1). 385–385. 29 indexed citations
9.
Minieri, Valentina, Marco De Dominici, Patrizia Porazzi, et al.. (2018). Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia. Cancer Research. 78(20). 5793–5807. 15 indexed citations
10.
Tefferi, Ayalew, Mythri Mudireddy, Francesco Mannelli, et al.. (2018). Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts. Leukemia. 32(5). 1200–1210. 93 indexed citations
11.
Golay, Josée, Rachele Alzani, Clara Albanese, et al.. (2018). Cord blood–derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors. Cytotherapy. 20(8). 1077–1088. 14 indexed citations
12.
Dominici, Marco De, Patrizia Porazzi, Angela Rachele Soliera, et al.. (2017). Targeting CDK6 and BCL2 Exploits the “MYB Addiction” of Ph+ Acute Lymphoblastic Leukemia. Cancer Research. 78(4). 1097–1109. 20 indexed citations
13.
Martinelli, Giovanni, Nicolas Boissel, Patrice Chevallier, et al.. (2017). Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study. Journal of Clinical Oncology. 35(16). 1795–1802. 298 indexed citations breakdown →
14.
Golay, Josée, Olga Pedrini, Chiara Capelli, et al.. (2017). Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance. Cytotherapy. 20(2). 262–270. 15 indexed citations
15.
Mariotti, Jacopo, Francesco Maura, Francesco Spina, et al.. (2014). Impact of Cytomegalovirus Replication and Cytomegalovirus Serostatus on the Outcome of Patients with B Cell Lymphoma after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(6). 885–890. 32 indexed citations
16.
Tefferi, Ayalew, Francesco Passamonti, Tiziano Barbui, et al.. (2013). Phase 3 Study Of Pomalidomide In Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis With RBC-Transfusion-Dependence. Blood. 122(21). 394–394. 24 indexed citations
17.
Raimondi, R, Alberto Tosetto, Rosi Oneto, et al.. (2012). Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study. Blood. 120(6). 1327–1333. 81 indexed citations
18.
Barbui, Tiziano, Alessandra Carobbio, Francisco Cervantes, et al.. (2009). Thrombosis in primary myelofibrosis: incidence and risk factors. Blood. 115(4). 778–782. 196 indexed citations
19.
Gianni’, Maurizio, Alessandro Rambaldi, Edoardo Parrella, et al.. (2009). Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RARα and PML-RARα. Cancer Research. 69(3). 1016–1026. 48 indexed citations
20.
Carobbio, Alessandra, Guido Finazzi, Elisabetta Antonioli, et al.. (2008). Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia. Blood. 112(8). 3135–3137. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maher Albitar Breakdown of academic impact, for papers by Deborah A. Thomas Breakdown of academic impact, for papers by John F. Seymour Breakdown of academic impact, for papers by James D. Griffin Breakdown of academic impact, for papers by Zeev Estrov Breakdown of academic impact, for papers by Tadeusz Robak Breakdown of academic impact, for papers by Stefan Faderl Breakdown of academic impact, for papers by William G. Wierda Breakdown of academic impact, for papers by Wolfgang Hiddemann Breakdown of academic impact, for papers by Michele Baccarani
Rankless by CCL
2026